| Ytd | -50.53% | |
| 1y | -57.84% |
| Open | 141.25 | Prev Close | 141.55 | Low | 140.03 | High | 142.17 | Mkt Cap | 9.75B |
| Vol | 2.51M | Avg Vol | 1.65M | EPS | 5.33 | P/E | 26.38 | Forward P/E | 18.23 |
| Beta | 1.08 | Short Ratio | 2.23 | Inst. Own | 107.11% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 151.02 | 200-d Avg | 202.51 | 1yr Est | 171.91 |
PODD News
ACTON, Mass.--(BUSINESS WIRE)--Insulet Corporation (NASDAQ: PODD), the global leader in tubeless ins
California State Teachers Retirement System grew its holdings in shares of Insulet Corporation (NASD
Amundi increased its holdings in shares of Insulet Corporation (NASDAQ: PODD) by 13.6% during the un
Insulet Corporation (PODD) Presents at Wells Fargo 21st Annual Healthcare Conference Transcript
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
PODD's Omnipod 5 adoption, product expansion and raised international growth outlook support its gro
The Zacks Style Scores offers investors a way to easily find top-rated stocks based on their investi
Insulet (PODD) reported earnings 30 days ago. What's next for the stock?
During the quarter, we initiated a position in Advanced Drainage Systems, the leading U.S. manufactu
[url="]Faruqi and Faruqi, LLP[/url], a leading national securities law firm, is investigating potent
NEW YORK--(BUSINESS WIRE)---- $PODD #ClassAction--Faruqi & Faruqi, LLP, a leading national securitie
New York, New York--(Newsfile Corp. - August 31, 2026) - WHY: Rosen Law Firm, a global investor righ
NEW YORK, Aug. 31, 2026 (GLOBE NEWSWIRE) -- Bronstein, Gewirtz & Grossman, LLC, a nationally recogni
Insulet's SEC Filings Touted Quality Assurance Inspections "At Various Steps in the Manufacturing Cy
LOS ANGELES--(BUSINESS WIRE)---- $PODD--PODD Investors Have Opportunity to Lead Insulet Corporation
Insulet Corporation Sued for Securities Law Violations - Contact the DJS Law Group to Discuss Your R
Insulet Corporation Investor Alert: Contact SBS by August 31, 2026 for Opportunity to Lead Securitie
LOS ANGELES, Aug. 31, 2026 /PRNewswire/ -- The DJS Law Group reminds investors of a class action law
LOS ANGELES, Aug. 31, 2026 /PRNewswire/ -- Schall Brown & Schwartz LLP, a national shareholder right
Faruqi & Faruqi, LLP Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suff
The FDA authorized Abbott's Libre Duo 10 Day, the first wearable tracking both glucose and keton
Canaccord Genuity analyst William Plovanic maintains Insulet (NASDAQ:PODD) with a Buy and lowers
Leerink Partners analyst Mike Kratky downgrades Insulet (NASDAQ:PODD) from Outperform to Market P
TD Cowen analyst Mathew Blackman maintains Insulet (NASDAQ:PODD) with a Hold and lowers the price
UBS analyst Patrick Wood maintains Insulet (NASDAQ:PODD) with a Neutral and lowers the price targ
RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the
Bernstein analyst Lee Hambright maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the
Benchmark analyst Bruce D. Jackson maintains Insulet (NASDAQ:PODD) with a Buy and lowers the pric
Stifel analyst Jonathan Block maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price tar
Analysts changed outlook on top names: JP Morgan cut price target for Insulet, HC Wainwright slashed
Top Wall Street analysts changed outlook on top names. See all changes on analyst ratings page. HUBS
Insulet Corp. (NASDAQ:PODD) reported strong Q2 earnings but lowered revenue outlook for 2021. Analy
Wells Fargo analyst Lawrence Biegelsen downgrades Insulet (NASDAQ:PODD) from Overweight to Equal-
JP Morgan analyst Robbie Marcus downgrades Insulet (NASDAQ:PODD) from Overweight to Neutral and l
Truist Securities analyst Richard Newitter downgrades Insulet (NASDAQ:PODD) from Buy to Hold and
Gold posts its biggest one-day gain since February and the Dow sets a record as Iran deal hopes cool
Gainers Zhengye Biotechnology (NASDAQ:ZYBT) stock increased by 107.0% to $2.65 during Wednesday'
Insulet (PODD) stock falls despite beating Q2 earnings as the company lowers its full-year 2026 reve
Insulet (NASDAQ:PODD) FY2026 expected to be more than $6.46 vs $6.43 Est. lowers FY2026 sales outlo
Insulet (NASDAQ:PODD) reported quarterly earnings of $1.66 per share which beat the analyst consensu
The partnership introduces The Mind in Range Collection, a set of tailored mindfulness resources ava
Truist Securities analyst Richard Newitter maintains Insulet (NASDAQ:PODD) with a Buy and lowers
RBC Capital analyst Shagun Singh maintains Insulet (NASDAQ:PODD) with a Outperform and lowers the
Stifel analyst Jonathan Block maintains Insulet (NASDAQ:PODD) with a Buy and lowers the price tar
Citigroup analyst Joanne Wuensch maintains Insulet (NASDAQ:PODD) with a Neutral and raises the pr
FDA classified Insulet's Omnipod pod recall as Class I after reports of insulin under-delivery l
Evercore ISI Group analyst Daniel Markowitz maintains Insulet (NASDAQ:PODD) with a Outperform and
Spain is the 26th country where Insulet sells Omnipod, and the 20th country where Omnipod 5 is avail
Wall Street analysts changed outlook on top names, including MCRB, SAFX. See analyst ratings page fo
Deutsche Bank analyst Kieran Ryan initiates coverage on Insulet (NASDAQ:PODD) with a Buy rating a